Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biomarker

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777491

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777491

Psychiatric Digital Biomarkers

PUBLISHED:
PAGES: 386 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Psychiatric Digital Biomarkers Market to Reach US$2.2 Billion by 2030

The global market for Psychiatric Digital Biomarkers estimated at US$612.5 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 24.1% over the analysis period 2024-2030. Wearable, one of the segments analyzed in the report, is expected to record a 25.7% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Mobile-based Applications segment is estimated at 24.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.9 Million While China is Forecast to Grow at 32.1% CAGR

The Psychiatric Digital Biomarkers market in the U.S. is estimated at US$166.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$547.6 Million by the year 2030 trailing a CAGR of 32.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.2% and 21.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 20.3% CAGR.

Global Psychiatric Digital Biomarkers Market - Key Trends & Drivers Summarized

Why Are Psychiatric Digital Biomarkers Revolutionizing Mental Health Diagnostics?

The emergence of psychiatric digital biomarkers is transforming the landscape of mental health diagnostics by providing objective, quantifiable measures for psychiatric disorders. Traditional diagnostic methods for mental health conditions such as depression, anxiety, schizophrenia, and bipolar disorder rely heavily on subjective patient assessments and clinician interpretations. This lack of objective measurement has contributed to delayed diagnoses, ineffective treatments, and inconsistent monitoring of disease progression. Psychiatric digital biomarkers, derived from passive and active data collection methods such as smartphone usage patterns, voice recordings, sleep tracking, facial expressions, and physiological signals, offer a groundbreaking solution to these challenges. With advances in artificial intelligence and machine learning, these biomarkers can identify subtle behavioral and cognitive patterns that may indicate early-onset psychiatric conditions. The growing adoption of wearable technology, mobile health applications, and telemedicine has further accelerated the integration of psychiatric digital biomarkers into clinical practice, enabling real-time mental health monitoring and personalized treatment interventions.

How Are AI and Machine Learning Enhancing Digital Biomarker Accuracy?

The application of artificial intelligence (AI) and machine learning algorithms in psychiatric digital biomarker research has significantly improved the accuracy and predictive power of mental health assessments. AI-driven analytics can process vast amounts of data from multiple sources, detecting patterns and correlations that human clinicians might overlook. For instance, sentiment analysis of voice recordings can identify emotional distress, while keystroke dynamics and speech cadence changes can indicate cognitive decline or depressive states. Advanced machine learning models can also integrate physiological data such as heart rate variability and sleep cycle irregularities to provide a more comprehensive view of a patient’s mental health status. As AI models continue to evolve, their ability to refine diagnostic precision and predict psychiatric episodes will likely increase, making digital biomarkers an essential tool for early intervention and treatment optimization. The integration of AI-based mental health tools into existing healthcare infrastructures is paving the way for large-scale adoption, bridging the gap between traditional psychiatry and digital therapeutics.

What Factors Are Driving the Adoption of Digital Biomarkers in Psychiatry?

The increasing prevalence of mental health disorders worldwide, combined with the demand for accessible and scalable diagnostic tools, has fueled the adoption of psychiatric digital biomarkers. The rise of digital health initiatives and the shift toward remote patient monitoring have further strengthened the market, as clinicians seek non-invasive, cost-effective solutions for tracking psychiatric conditions. The COVID-19 pandemic highlighted the need for virtual mental health solutions, accelerating the development and deployment of AI-driven diagnostic platforms and mental health apps. Additionally, regulatory bodies are recognizing the potential of digital biomarkers, with initiatives aimed at standardizing their use in clinical trials and therapeutic monitoring. The integration of psychiatric digital biomarkers into clinical workflows is also being supported by growing investment in digital health startups, partnerships between tech companies and healthcare providers, and the expansion of precision psychiatry initiatives.

What Are the Key Drivers Shaping the Psychiatric Digital Biomarkers Market?

The growth in the global psychiatric digital biomarkers market is driven by several factors, including the increasing burden of mental health disorders, advancements in AI-driven diagnostics, and the widespread adoption of wearable technology. The expansion of telemedicine and remote healthcare solutions has created a conducive environment for digital biomarkers to become mainstream in psychiatric care. The rising acceptance of mobile health applications for mental health self-assessment and intervention has also contributed to market growth. Government initiatives promoting digital health innovation, along with growing insurance coverage for mental health treatments, are further accelerating adoption. Additionally, the increasing demand for personalized medicine and precision psychiatry is fueling research into biomarker-driven treatment strategies, ensuring that digital biomarkers will continue to shape the future of psychiatric healthcare.

SCOPE OF STUDY:

The report analyzes the Psychiatric Digital Biomarkers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Wearable, Mobile-based Applications, Sensors, Others); Clinical Practice (Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers, Others); End-Use (Healthcare companies, Healthcare Providers, Payers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • ActiGraph LLC
  • Adherium Limited
  • AliveCor Inc.
  • Altoida Inc.
  • Amgen Inc.
  • Aural Analytics
  • Behavidence
  • Biogen Inc.
  • Brainomix
  • Clario
  • Earkick
  • Empatica Inc.
  • Encrypgen
  • Feel Therapeutics
  • Healthereum
  • HIVE Blockchain Technologies Ltd.
  • Huma
  • Imagene AI
  • IXICO plc
  • Kinsa Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32723

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Psychiatric Digital Biomarkers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Mental Health Crisis Throws the Spotlight on the Need for Scalable and Objective Psychiatric Assessment Tools
    • Expansion of Digital Phenotyping and Passive Sensing Technologies Drives Adoption of Psychiatric Digital Biomarkers
    • Advancements in Wearables, Smartphones, and IoT Devices Strengthen Business Case for Continuous Behavioral Monitoring
    • Growing Interest in Precision Psychiatry Spurs Demand for Data-Driven Biomarker-Based Diagnostic Models
    • Integration of Artificial Intelligence and Machine Learning Enhances Predictive Validity and Pattern Recognition in Digital Biomarker Development
    • Emergence of Voice, Speech, and Language Biomarkers Propels Innovation in Remote Monitoring of Psychiatric Conditions
    • Widening Application of Facial Expression and Microgesture Analysis Expands Real-Time Mood and Emotion Tracking Capabilities
    • Regulatory Emphasis on Validated Digital Endpoints Drives Standardization and Market Readiness of Digital Biomarkers
    • Rise in Smartphone-Based Cognitive Testing and Neuromotor Assessments Accelerates Consumer-Grade Tool Adoption
    • Collaborations Between Tech Companies and Psychiatric Research Institutions Fuel Breakthroughs in Digital Biomarker Validation
    • Growing Use of Sleep, Activity, and Circadian Rhythm Data Enhances Passive Biomarker Integration in Mental Health Monitoring
    • Expansion of Telepsychiatry and Virtual Mental Health Platforms Spurs Seamless Integration of Digital Biomarker Feedback Loops
    • Shift Toward Preventive and Early Detection Models in Mental Healthcare Drives Uptake of Digital Biomarker Technologies
    • Increasing Need for Remote Clinical Trials and Decentralized Research Environments Strengthens Adoption of Mobile-Based Biomarkers
    • Focus on Real-World Evidence and Longitudinal Patient Monitoring Enhances Market Potential of Digital Biomarkers in Psychiatry
    • Rising Interest in Gamified Mental Health Assessments and Digital Cognitive Tests Generates New Engagement Modalities
    • Challenges in Data Privacy, Security, and Consent Create Demand for Transparent Governance Frameworks and Ethical AI
    • Integration of Digital Biomarkers into Electronic Health Records (EHRs) Enhances Clinical Decision Support and Personalized Care
    • Adoption of Digital Biomarkers in Pediatric and Adolescent Psychiatry Expands Demographic Reach of Non-Invasive Tools
    • Development of Cross-Platform Interoperability and API Ecosystems Drives Scalability in Psychiatric Biomarker Solutions
    • Increased Venture Capital and Pharma Investment in Digital Mental Health Startups Fuels Innovation and Commercialization
    • Growing Demand from Payers and Employers for Outcomes-Based Mental Health Solutions Accelerates Validation of Digital Biomarkers in Value-Based Care Models
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Psychiatric Digital Biomarkers Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Wearable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Wearable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Wearable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mobile-based Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mobile-based Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Mobile-based Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Healthcare companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Healthcare companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Healthcare companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diagnostic Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Monitoring Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Monitoring Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Monitoring Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Predictive & Prognostic Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Predictive & Prognostic Psychiatric Digital Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Predictive & Prognostic Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Clinical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Clinical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Clinical Practices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • JAPAN
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • CHINA
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • EUROPE
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Psychiatric Digital Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • FRANCE
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • GERMANY
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • INDIA
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Psychiatric Digital Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Psychiatric Digital Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030
  • AFRICA
    • Psychiatric Digital Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Psychiatric Digital Biomarkers by Type - Wearable, Mobile-based Applications, Sensors and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Psychiatric Digital Biomarkers by Type - Percentage Breakdown of Value Sales for Wearable, Mobile-based Applications, Sensors and Other Types for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Psychiatric Digital Biomarkers by End-Use - Healthcare Providers, Payers, Other End-Uses and Healthcare companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Psychiatric Digital Biomarkers by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Payers, Other End-Uses and Healthcare companies for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Psychiatric Digital Biomarkers by Clinical Practice - Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Psychiatric Digital Biomarkers by Clinical Practice - Percentage Breakdown of Value Sales for Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive & Prognostic Psychiatric Digital Biomarkers and Other Clinical Practices for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!